Product Images Eribulin Mesylate
View Photos of Packaging, Labels & Appearance
- PRINCIPAL DISPLAY PACKAGE - Eribulin Mesylate Injection 1 mg/2 mL Carton - eribulin k32 carton v3
- Figure 1 - eribulin k32 figure1 v2
- Figure 2 - eribulin k32 figure2 v2
- Structural formula - eribulin k32 structure v2
- PRINCIPAL DISPLAY PACKAGE - Eribulin Mesylate Injection 1 mg/2 mL Vial Label - eribulin k32 vial v2
Product Label Images
The following 5 images provide visual information about the product associated with Eribulin Mesylate NDC 40033-364 by Kindos Pharmaceuticals Co., Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PACKAGE - Eribulin Mesylate Injection 1 mg/2 mL Carton - eribulin k32 carton v3
This text contains information about Eribulin Mesylate Injection, including dosage, composition, storage instructions, and cautions related to its cytotoxic nature. It provides details such as the concentration of the drug per volume, temperature storage requirements, and the need for pH adjustment. The product is intended for intravenous use, and each single-dose vial should be discarded if unused. Additional details may be found in the prescribing information. The drug is manufactured by a company located in China.*
Figure 1 - eribulin k32 figure1 v2
This text provides information on a research study involving eribulin mesylate injection with a total of 508 participants. The data includes a timeline spanning up to 36 months and shows the number of patients at risk at different time points. It also mentions a control group with 254 participants.*
Figure 2 - eribulin k32 figure2 v2
Structural formula - eribulin k32 structure v2
PRINCIPAL DISPLAY PACKAGE - Eribulin Mesylate Injection 1 mg/2 mL Vial Label - eribulin k32 vial v2
This description provides information on a sterile solution, Eribulin Mesylate injection intended for intravenous use. It contains 1 mg/2 ml (0.5 mg/ml) and should not be frozen or refrigerated. The storage recommendations are 15°C - 30°C (50°F - 86°F). The product is a cytotoxic agent and comes in a single-dose vial. Specific dosage instructions are available in the accompanying prescribing information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
